Search
Showing 1 - 16 of 16 results
Obesity Options in the Ozempic Era: An Expert’s Insights on BMI, GLP-1s and Surgery
Treating obesity is among the PCP's everyday duties, but when does a patient's body composition put them at risk and which treatments are appropriate?First Global Guidelines for Pregnancy and Inflammatory Bowel Disease Developed
For women with inflammatory bowel disease (IBD), pregnancy can be an uncertain time due to limited clinical data about how IBD medications impact pregnancy outcomes and infants who have been exposed to IBD medications in utero.How We Could Test for Unhealthy Alcohol Use Before It's Too Late
A new study finds that a blood test may be a more reliable indicator of liver disease than asking how much a person drinks.IBS Diarrhea in Primary Care: Shorter Routes to Diagnosis and Symptom Assuagement
Diarrhea related to irritable bowel syndrome is common, yet because it's a functional – not anatomical – disorder, providers frequently run more tests than necessary while patients worry and wait in discomfort.Physician Referral Guide: Liver Tumor Clinic
THE UCSF LIVER TUMOR CLINIC provides specialized multidisciplinary care for patients with early- and intermediate-stage liver cancer and benign liver tumors.Using AI to Improve Detection of Rare Diseases
Acute hepatic porphyria (AHP) is a rare genetic disease with symptoms that overlap with many other conditions, making it extremely challenging to diagnose. Its symptoms mostly affect women with severe, sometimes life-threatening attacks that include abdominal pain, nausea, vomiting, limb weakness and anxiety.Panel Issues First Guidelines to Prevent Anal Cancer in People With HIV
Results from a national study led by UC San Francisco informed the first guidelines at the federal level in the United States to detect and treat anal cancer precursor lesions in people with HIV to reduce the risk of developing anal cancer.Can a New Drug Candidate Cure Pancreatic Cancer?
UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.Can AI Predict Serious Adverse Events From IBD Therapies?
In a groundbreaking study, UCSF researchers used a new clinical large language model (LLM) to identify serious adverse events (SAEs) occurring in patients treated with immunosuppressants to manage inflammatory bowel disease (IBD).Navigate the New World of Genetic Testing: Tips and Tools for PCPs
In this practical yet nuanced talk, gastroenterologist Aparajita Singh, MD, MPH, describes technological advances and dwindling barriers that are making tests for pathogenic gene variants more valuable and available than ever before.Pain in the Butt: Tips on Diagnosing and Caring for Hemorrhoids and Fissures
Diana Ziser Rego, an adult-gerontology nurse practitioner with expertise in lower GI disorders, describes efficient routes to identifying hemorrhoids and anal fissures, offering tips on what questions to ask, straightforward management plans and guidance on when to refer.Physician Survey Shows Lack of Understanding of the FDA’s Approval Process
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than they are, according to a national survey of physicians conducted by researchers at UC San Francisco (UCSF).Primary Care of the IBD Patient: Risk Factors, Symptoms and the Value of Timely Therapeutics
In this update on inflammatory bowel disease, gastroenterologist Kendall Beck, MD, notes contributing causes, explains which tests have value, gives keys to distinguishing ulcerative colitis and Crohn’s...The Evidence on Incidentalomas: When to Investigate, When to Rest Easy
This presentation from radiologist Hailey H. Choi, MD, supplies straightforward criteria to help providers assess lesions ranging from thyroid and adrenal nodules to ovarian cysts to pancreatic and liver lesions.A Guide to GERD: Managing Symptoms and Complications of a Common Condition
With gastroesophageal reflux disease affecting 40% of the U.S. population every month, primary care providers need a straightforward plan for initiating therapy, as well as an up-to-date understanding of causes and treatment complications.Liver Transplant Program and Referral Information
With more than 13,000 people in the United States with end-stage liver disease awaiting a liver transplant,UCSF has made liver transplantation services a high priority.